Suppr超能文献

我们有赢家了吗?支持立体定向放疗在肝癌治疗中的应用。

Do We Have a Winner? Advocating for SBRT in HCC Management.

作者信息

Safavi Amir H, Dawson Laura A, Mesci Aruz

机构信息

Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

出版信息

Clin Transl Radiat Oncol. 2024 Feb 2;45:100740. doi: 10.1016/j.ctro.2024.100740. eCollection 2024 Mar.

Abstract

•Stereotactic body radiotherapy (SBRT) is a safe and effective locoregional therapy for inoperable patients with HCC.•SBRT compares favorably with other local therapies in terms of local control, survival, morbidity, and cost-effectiveness.•SBRT should be considered and discussed in multidisciplinary management of appropriate HCC patients.•Advances in SBRT and novel combinations with systemic therapy may further widen the therapeutic index in HCC.

摘要

•立体定向体部放疗(SBRT)是一种针对无法手术的肝癌患者的安全有效的局部区域治疗方法。

•在局部控制、生存率、发病率和成本效益方面,SBRT与其他局部治疗方法相比具有优势。

•在合适的肝癌患者多学科管理中,应考虑并讨论SBRT。

•SBRT的进展以及与全身治疗的新型联合应用可能会进一步扩大肝癌的治疗指数。

相似文献

1
Do We Have a Winner? Advocating for SBRT in HCC Management.
Clin Transl Radiat Oncol. 2024 Feb 2;45:100740. doi: 10.1016/j.ctro.2024.100740. eCollection 2024 Mar.
2
Exploring the Evolving Landscape of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma.
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102386. doi: 10.1016/j.jceh.2024.102386. Epub 2024 Aug 3.
4
Radiotherapy for HCC: Ready for prime time?
JHEP Rep. 2019 May 21;1(2):131-137. doi: 10.1016/j.jhepr.2019.05.004. eCollection 2019 Aug.
6
Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
Yonsei Med J. 2018 Oct;59(8):912-922. doi: 10.3349/ymj.2018.59.8.912.
7
Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review.
Cost Eff Resour Alloc. 2020 Jan 10;18:1. doi: 10.1186/s12962-019-0198-z. eCollection 2020.
9
Stereotactic body radiotherapy is an alternative to radiofrequency ablation for single HCC ≤5.0 cm.
JHEP Rep. 2024 Jun 25;6(10):101151. doi: 10.1016/j.jhepr.2024.101151. eCollection 2024 Oct.

引用本文的文献

1
The prognostic utility of IGF-1 in hepatocellular carcinoma treated with stereotactic body radiotherapy.
Clin Transl Radiat Oncol. 2024 Nov 12;50:100887. doi: 10.1016/j.ctro.2024.100887. eCollection 2025 Jan.
2
Feasibility of using contrast-free quantitative magnetic resonance imaging for liver sparing stereotactic ablative body radiotherapy.
Clin Transl Radiat Oncol. 2024 Sep 13;49:100859. doi: 10.1016/j.ctro.2024.100859. eCollection 2024 Nov.
3
Complex Multi-site Stereotactic Body Re-irradiation With CT-Guided Online Adaptive Radiotherapy.
Cureus. 2024 Sep 3;16(9):e68559. doi: 10.7759/cureus.68559. eCollection 2024 Sep.

本文引用的文献

3
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines.
Int J Radiat Oncol Biol Phys. 2024 Feb 1;118(2):337-351. doi: 10.1016/j.ijrobp.2023.08.015. Epub 2023 Aug 18.
5
Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases.
Cancers (Basel). 2023 May 17;15(10):2786. doi: 10.3390/cancers15102786.
6
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Hepatology. 2023 Dec 1;78(6):1922-1965. doi: 10.1097/HEP.0000000000000466. Epub 2023 May 22.
8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验